Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycogen synthase kinase 3 beta | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.1065 | 0.5766 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.1774 | 0.9826 | 0.9826 |
Brugia malayi | intracellular kinase | 0.0058 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1805 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.1065 | 0.5766 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1805 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.1065 | 0.5766 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0058 | 0 | 0.5 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.1805 | 1 | 1 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0058 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.077 | 0.4077 | 0.4077 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1805 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.1774 | 0.9826 | 0.9826 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.077 | 0.4077 | 0.4077 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.077 | 0.4077 | 0.4077 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0058 | 0 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.1805 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1774 | 0.9826 | 0.9826 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.1774 | 0.9826 | 0.9826 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.077 | 0.4077 | 0.4077 |
Onchocerca volvulus | 0.1805 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.1805 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1774 | 0.9826 | 0.9826 |
Loa Loa (eye worm) | hypothetical protein | 0.1035 | 0.5591 | 0.5591 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1805 | 1 | 1 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0058 | 0 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.1065 | 0.5766 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0058 | 0 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.1065 | 0.5766 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.36 uM | Inhibition of recombinant human GSK3 using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 10 mins followed by [33P-gamma]-ATP addition measured after 30 mins by liquid scintillation counting analysis | ChEMBL. | 23683591 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.